Tempus Pro Monitor Registry

计划入组 103 人 · 首次发布于 2022 年 10 月 20 日

NOrthwestern Tempus AI-enaBLed Electrocardiography (NOTABLE) Trial

计划入组 1,000 人 · 首次发布于 2024 年 7 月 22 日

TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)

计划入组 200 人 · 首次发布于 2022 年 2 月 25 日

Tempol

C₉H₁₈NO₂

TREX-1 inhibitor(Tempest)

CD59 Inhibitors (Temple University)

Tempest Therapeutics

United States

TELUS

WOODLANDS HEALTH CAMPUS

Singapore

Tempus Launches TIME Precision Network to Accelerate Phase I Clinical Trial Enrollment

Tempus AI Strengthens Precision Medicine Platform with Strategic Deep 6 AI Acquisition

Tempus AI Reports Strong Growth and Strategic Acquisition of Ambry Genetics in Q4 2024